ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS

• Conditions: Skin Cancer; Skin Lymphoma; Skin Squamous Cell Carcinoma; Metastatic Basal Cell Carcinoma; Advance Directives; Oncology; Melanoma

• Registration Number: NCT03822988
• Lead Sponsor: Central Hospital, Nancy, France

Brief Summary

The law about advance directives is evolving but, in France, few people write it.

Te main endpoint of this research is to estimate the proportion of patients who have written their advance directives or considering doing so in onco-dermatologic population. If this rate remains low, some insights on the reasons will be able to be advanced looking at the point of view and opinion of patients about this topic.

Seconds endpoints are :

For patients against or not planning to write it, understand their reasons

Estimate the proportion of patients requesting information and understand how they would like to receive it.

Investigate a possible association between the stage of the oncological disease and the positioning of the patient concerning advance directives.

Detailed Description

Not available

Study Timeline

• Status Verified: 2019-01
• Study Start: 2019-01-21
• Study First Submitted: 2019-01-28
• Study First Submitted QC: 2019-01-28
• Last Update Submitted: 2019-01-28
• Study First Posted: 2019-01-30
• Last Update Posted: 2019-01-30
• Primary Completion: 2019-06-20
• Study Completion: 2019-06-20

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

> 18 ya

With one of the diagnoses below:

• Melanoma
• Skin lymphoma
• Meckel Carcinoma
• localy advanced or metastatic Basal cell carcinoma or squamous cell carcinoma

Exclusion Criteria

Patients not in possession of all of its cognitive abilities Patients who can't read patients who don't speak french

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Writing by the patient of its advance directives	when the patient complete the survey	Writing by the patient of his advance directves and, if not writing, positioning of the patient (rather favorable or rather unfavorable) as to the writing of his advance directives.

Secondary Outcome Measures

Name	Time	Method
Patient wishing to be more informed about the adavance directives during its management and, if so, by what means.	when the patient complete the survey
reason for not writing advance directives	when the patient complete the survey	In patients who have not written their advance directives: reason for not writing the advance directives.

Trial Locations

Locations (1)

CHRU Nancy-Brabois hospital; 🇫🇷 Vandœuvre-lès-Nancy, France